Burns Brigid R, Hofmeister Erik H, Brainard Benjamin M
Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
Vet Anaesth Analg. 2014 Mar;41(2):186-90. doi: 10.1111/vaa.12100. Epub 2013 Nov 21.
To determine if dogs that undergo laparotomy for cholecystectomy suffer from a greater number or magnitude of perianesthetic complications, including hypotension, hypothermia, longer recovery time, and lower survival rate, than dogs that undergo laparotomy for hepatic surgery without cholecystectomy.
Retrospective cohort study.
One hundred and three dogs, anesthetised between January 2007 and October 2011.
The variables collected from the medical record included age, weight, gender, surgical procedure, pre-operative bloodwork, American Society of Anesthesiologists (ASA) status, emergency status, total bilirubin concentration, anesthetic agents administered, body temperature nadir, final body temperature, hypotension, duration of hypotension, blood pressure nadir, intraoperative drugs, anesthesia duration, surgery duration, time to extubation, final diagnosis, days spent in the intensive care unit (ICU), total bill, survival to discharge, and survival to follow-up.
No significant difference in body temperature nadir, final temperature, presence of hypotension, duration of hypotension, blood pressure nadir, the use of inotropes, or final outcome was found between dogs undergoing cholecystectomy and dogs undergoing exploratory laparotomy for other hepatic disease. Dogs that had cholecystectomy had longer anesthesia durations and longer surgery durations than dogs that did not have cholecystectomy. No significant differences existed for temperature nadir (34.8 versus 35.3°C; non-cholecystectomy versus cholecystectomy), final temperature (35.6 versus 35.9°C), time to extubation (30 versus 49 minutes), duration of hypotension (27 versus 21 minutes), or MAP nadir (56 versus 55 mmHg). Hypotension occurred in 66% and 74% and inotropes were used in 64% and 53%, for non-cholecystectomy and cholecystectomy patients, respectively.
Dogs that underwent cholecystectomies did not suffer a greater number of anesthesia complications than did dogs undergoing hepatic surgery without cholecystectomies.
确定接受胆囊切除术的剖腹手术犬与接受无胆囊切除术的肝脏手术的剖腹手术犬相比,是否会出现更多或更严重的围麻醉期并发症,包括低血压、体温过低、恢复时间延长和生存率降低。
回顾性队列研究。
2007年1月至2011年10月期间麻醉的103只犬。
从病历中收集的变量包括年龄、体重、性别、手术程序、术前血液检查、美国麻醉医师协会(ASA)状态、急诊状态、总胆红素浓度、使用的麻醉剂、体温最低点、最终体温、低血压、低血压持续时间、血压最低点、术中用药、麻醉持续时间、手术持续时间、拔管时间、最终诊断、在重症监护病房(ICU)的天数、总费用、出院生存率和随访生存率。
接受胆囊切除术的犬与因其他肝脏疾病接受剖腹探查术的犬在体温最低点、最终体温、低血压的存在、低血压持续时间、血压最低点、使用血管活性药物或最终结局方面未发现显著差异。接受胆囊切除术的犬比未接受胆囊切除术的犬麻醉持续时间更长,手术持续时间更长。体温最低点(34.8对35.3°C;非胆囊切除术对胆囊切除术)、最终体温(35.6对35.9°C)、拔管时间(30对49分钟)、低血压持续时间(27对21分钟)或平均动脉压最低点(56对55 mmHg)无显著差异。非胆囊切除术和胆囊切除术患者的低血压发生率分别为66%和74%,血管活性药物使用率分别为64%和53%。
接受胆囊切除术的犬与未接受胆囊切除术的肝脏手术犬相比,麻醉并发症数量并不更多。